img_4482CURE member organization The Sino-American Pharmaceutical Professionals Association Connecticut (SAPA-CT) had its third annual conference in New Haven on Saturday, this past weekend on “Bringing Value to Patients through Technology Advancements and Global Innovations.  Of the almost 400 participants, many members of the CURE organization were on the scene – Alexion, Boehringer Ingelheim, Yale, HLK, University of New Haven, Quinnipiac University, and Dilworth, IP  to name a few.

img_4478Two distinguished speakers led off the morning session.  The first speaker was Henry C. Lee, famed Professor in Forensic Science of the University of New Haven.  Professor Lee gave a fascinating and entertaining presentation about his passion for his work and the extent of his accomplishments in serving to assist in solving serious crimes resulting from wars and from modern society.

Our second equally accomplished speaker was Yung-Chi (Tommy) Cheng, the Henry Bronson Professor of img_4486Pharmacology at Yale and Member of Academia Sinica, Republic of China.  Drugs invented by Dr. Cheng are routinely used to treat cancer, HIV/AIDS and hepatitis B.  Yale and Cheng, together with David Scheer (link), founded Achillion Pharmaceuticals (link), a New Haven-based company.  David Scheer is a member of the CURE Board and Achillion, the CURE network.  At Saturday’s conference Yung-Chi spoke about his strategy for converging Western and traditional Chinese medicine development to guide us globally to an improved quality of health.  In 2003, Dr. Cheng formed a consortium for the globalization of Chinese Medicine (tcmedicine.org). Readers may be interested in joining.